TIAA CREF Investment Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.39M | Sell |
15,893
-9,605
| -38% | -$841K | ﹤0.01% | 2167 |
|
|
2018
Q4 | $3.58M | Sell |
25,498
-9,239
| -27% | -$1.3M | ﹤0.01% | 1584 |
|
|
2018
Q3 | $8.87M | Sell |
34,737
-3,330
| -9% | -$851K | 0.01% | 1182 |
|
|
2018
Q2 | $9.7M | Buy |
38,067
+20,574
| +118% | +$5.24M | 0.01% | 1170 |
|
|
2018
Q1 | $3.52M | Buy |
17,493
+12,166
| +228% | +$2.45M | ﹤0.01% | 1785 |
|
|
2017
Q4 | $767K | Sell |
5,327
-718
| -12% | -$103K | ﹤0.01% | 2594 |
|
|
2017
Q3 | $996K | Sell |
6,045
-851
| -12% | -$140K | ﹤0.01% | 2518 |
|
|
2017
Q2 | $936K | Buy |
6,896
+2,288
| +50% | +$311K | ﹤0.01% | 2580 |
|
|
2017
Q1 | $888K | Sell |
4,608
-96
| -2% | -$18.5K | ﹤0.01% | 2568 |
|
|
2016
Q4 | $663K | Sell |
4,704
-498
| -10% | -$70.2K | ﹤0.01% | 2728 |
|
|
2016
Q3 | $759 | Buy |
5,202
+114
| +2% | +$17 | ﹤0.01% | 2672 |
|
|
2016
Q2 | $512K | Buy |
5,088
+229
| +5% | +$23K | ﹤0.01% | 2842 |
|
|
2016
Q1 | $650K | Sell |
4,859
-222
| -4% | -$29.7K | ﹤0.01% | 2687 |
|
|
2015
Q4 | $1.01M | Hold |
5,081
| – | – | ﹤0.01% | 2575 |
|
|
2015
Q3 | $802K | Sell |
5,081
-44
| -0.9% | -$6.95K | ﹤0.01% | 2701 |
|
|
2015
Q2 | $2.09M | Buy |
5,125
+1,675
| +49% | +$684K | ﹤0.01% | 2273 |
|
|
2015
Q1 | $1.58M | Buy |
3,450
+244
| +8% | +$112K | ﹤0.01% | 2369 |
|
|
2014
Q4 | $1.8M | Buy |
3,206
+96
| +3% | +$53.9K | ﹤0.01% | 2321 |
|
|
2014
Q3 | $1.63M | Sell |
3,110
-52
| -2% | -$27.3K | ﹤0.01% | 2356 |
|
|
2014
Q2 | $2.21M | Buy |
3,162
+1,178
| +59% | +$823K | ﹤0.01% | 2243 |
|
|
2014
Q1 | $919K | Buy |
1,984
+615
| +45% | +$285K | ﹤0.01% | 2686 |
|
|
2013
Q4 | $471K | Buy |
+1,369
| New | +$471K | ﹤0.01% | 2978 |
|